Get the Stockscreener App
0.5166
4.34%
0.0215
After Hours:
.52
0.0034
+0.66%
Eyenovia Inc stock is traded at $0.5166, with a volume of 1.26M.
It is up +4.34% in the last 24 hours and down -6.09% over the past month.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
See More
Previous Close:
$0.4951
Open:
$0.5
24h Volume:
1.26M
Relative Volume:
0.72
Market Cap:
$39.29M
Revenue:
-
Net Income/Loss:
$-27.26M
P/E Ratio:
-0.7487
EPS:
-0.69
Net Cash Flow:
$-27.81M
1W Performance:
+12.84%
1M Performance:
-6.09%
6M Performance:
-47.61%
1Y Performance:
-68.88%
1-Day Range:
$0.4951
$0.545
1-Week Range:
$0.44
$0.545
52-Week Range:
$0.37
$2.57
Eyenovia Inc Stock (EYEN) Company Profile
Name
Eyenovia Inc
Sector
Industry
Phone
813-766-9539
Address
295 MADISON AVENUE,, NEW YORK, NY
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Eyenovia Inc Stock (EYEN) Latest News
Eyenovia Inc [EYEN] Investment Guide: What You Need to Know - Knox Daily
Is Eyenovia Inc (EYEN) a good investment opportunity? - US Post News
Trading Day Review: Eyenovia Inc (EYEN) Gains Momentum, Closing at 0.50 - The Dwinnex
Eyenovia Announces Share Offering and Warrant Sale for Growth - TipRanks
SEC Form 424B5 filed by Eyenovia Inc. - Quantisnow
Eyenovia secures $4 million in registered direct offering - Investing.com India
Eyenovia secures $4 million in registered direct offering By Investing.com - Investing.com Canada
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering - ForexTV.com
Eyenovia Prices of $4 Million Registered Direct Offering - citybiz
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering - GlobeNewswire
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering - StockTitan
Eyenovia Announces U.S. Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Postoperative Inflammation Following Ocular Surgery - Vision Monday
Eyenovia Inc [EYEN] Shares Rise 2.89 % on Wednesday - Knox Daily
Eyenovia announces commercial availability of clobetasol, shares rise - MSN
Eyenovia launches FDA-approved clobetasol for ocular surgery - Investing.com
Eyenovia Announces Launch and Commercial Availability of - GlobeNewswire
Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery - StockTitan
Stocks of Eyenovia Inc (EYEN) are poised to climb above their peers - SETE News
Analyzing Eyenovia Inc (EYEN) After Recent Trading Activity - Knox Daily
What was Eyenovia Inc (EYEN)’s performance in the last session? - US Post News
Eyenovia Inc (EYEN)’s financial ratios: A comprehensive overview - The Dwinnex
Certain Warrants of Eyenovia, Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2024. - Marketscreener.com
Eyenovia faces Nasdaq delisting over share price dip By Investing.com - Investing.com Canada
Eyenovia faces Nasdaq delisting over share price dip - Investing.com
Eyenovia faces Nasdaq delisting over share price dip By Investing.com - Investing.com Australia
Eyenovia faces Nasdaq delisting over share price dip By Investing.com - Investing.com UK
Eyenovia Inc [EYEN] Shares Fall -1.59 % on Wednesday - Knox Daily
Eyenovia Inc (EYEN) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Financial Health Report: Eyenovia Inc (EYEN)’s Ratios Tell a Tale - The Dwinnex
There is no way Eyenovia Inc (EYEN) can keep these numbers up - SETE News
Eyenovia Inc (EYEN) requires closer examination - US Post News
Eyenovia Inc [EYEN] Chief Executive Officer makes an insider purchase of 27,071 shares worth 14077.0. - Knox Daily
A significant driver of top-line growth: Eyenovia Inc (EYEN) - SETE News
EYEN Shares Are Trading Higher Today: What You Need To Know - Benzinga
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - The Malaysian Reserve
Eyenovia Inc (EYEN) did well last session? - US Post News
Investor’s Delight: Eyenovia Inc (EYEN) Closes Weak at 0.49, Down -3.67 - The Dwinnex
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - The Manila Times
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercializati - ACROFAN USA
Eyenovia Announces Taiwan Export License Approval to Begin Shipment to the U.S. of Clobetasol Propionate Ophthalmic Suspension - Vision Monday
Eyenovia Inc [EYEN] Chief Executive Officer makes an insider acquire of 27,071 shares worth 14,077. - Knox Daily
Eyenovia Inc (EYEN) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
It makes sense and dollars to buy Eyenovia Inc (EYEN) stock - SETE News
Eyenovia Announces Taiwan Export License Approval to - GlobeNewswire
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S. - StockTitan
Was Eyenovia Inc (EYEN)’s session last reading good? - US Post News
What Did We Find About Insider Trading At Eyenovia Inc (NASDAQ: EYEN)? - Stocks Register
Eyenovia appoints Andrew Jones as new CFO - Investing.com India
Eyenovia appoints Andrew Jones as new CFO - Investing.com
Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com Australia
Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com Canada
Eyenovia Inc Stock (EYEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):